NEOK Bio, Inc. has emerged from stealth with $75 million in Series A funding led by ABL Bio to advance bispecific antibody drug conjugates for oncology.
Amount Raised
$75 Million
Round Type
Series A
Palo AltoBiotechnologyHealth CareInvestors
Description
NEOK Bio, Inc., a biotechnology company focused on developing novel antibody drug conjugates for cancer treatment, has raised $75 million in Series A financing. The funding, led by ABL Bio, will support the initiation of clinical studies for two bispecific ADC programs. NEOK aims to become a leader in bispecific ADCs in the U.S. and will leverage ABL's innovative technology for their development.
Quick answer
NEOK Bio raised $75 Million in a Series A round, dated November 4, 2025. Investors: ABL Bio and ABL Bio, Inc. NEOK Bio is based in Palo Alto, California, United States.
- How much did NEOK Bio raise?
- NEOK Bio raised $75 Million in a Series A round on November 4, 2025.
- Who invested in NEOK Bio?
- ABL Bio and ABL Bio, Inc. are named as investors in this round.
- What does NEOK Bio do?
- NEOK Bio, Inc. is a biotechnology company focused on the development of novel antibody drug conjugates (ADCs) that are designed to improve outcomes for cancer patients.
- Where is NEOK Bio based and how big is it?
- NEOK Bio is based in Palo Alto, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as NEOK Bio that raised within 45 days of this round, from Fundz verified event records.
- Ikonisys raised $3.2M (Funding Round) on December 19, 2025.
- Rezubio Pharmaceuticals raised $20M (Series A) on December 19, 2025.
- Syremis Therapeutics raised $165M (Series A) on December 18, 2025.
- Addition Therapeutics raised $100M (Funding Round) on December 18, 2025.
- LeonaBio, Inc. raised $90M (Funding Round) on December 18, 2025.
- FoRx Therapeutics raised $50M (Series A) on December 18, 2025.
Who to call at NEOK Bio, and when
A new round usually means NEOK Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NEOK Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NEOK Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NEOK Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NEOK Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansNEOK Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.